Bacterial biofilms and infection;Biofilms bacterianos e infección

Anales del Sistema Sanitario de Navarra

Volumn 28, Issue 2, 2005, Pages 163-175

  Lasa, I ^a   Del Pozo, J L ^b   Penades J R ^c   Leiva, J ^b  

^a PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

Author keywords

Antibiotic resistance; Biofilms; Chronic infection; Exopolysaccharides; Medical devices

Indexed keywords

ANTIBIOTIC AGENT; ANTIBODY; ANTIINFECTIVE AGENT; BACTERIAL VACCINE; BIOMATERIAL; EXOPOLYSACCHARIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; BACTERIAL POLYSACCHARIDE;

ANTIBIOTIC RESISTANCE; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BIOFILM; CARDIOVASCULAR DISEASE; CHOLERA; DEVELOPING COUNTRY; DIPHTHERIA; ENDOCARDITIS; HAEMOPHILUS INFLUENZAE; HEART DISEASE; HUMAN; IMMUNE DEFICIENCY; INFECTION; MEDICAL INSTRUMENTATION; MORAXELLA CATARRHALIS; MORTALITY; OSTEOMYELITIS; OTITIS MEDIA; PHAGOCYTE; PROSTATITIS; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; TETANUS; URINARY TRACT INFECTION; WORLD HEALTH ORGANIZATION; ACUTE DISEASE; BACTERIUM; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG EFFECT; EQUIPMENT; FEMALE; GROWTH, DEVELOPMENT AND AGING; MALE; MICROBIOLOGY;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL VACCINES; BIOFILMS; CHRONIC DISEASE; DRUG RESISTANCE, BACTERIAL; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; MALE; POLYSACCHARIDES, BACTERIAL; PROSTHESIS-RELATED INFECTIONS;

EID: 27744498225     PISSN: 11376627     EISSN: 11376627     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. COSTERTON JW, LEWANDOWSKI Z, CALDWELL DE, KORBER DR, LAPPIN-SCOTT HM. Microbial biofilms. Annu Rev Microbiol 1995; 49: 711-745.
2. SUTHERLAND I. Biofilm exopolysaccharides: a strong and sticky framework. Microbiology 2001; 147: 3-9.
3. BRANDA SS, VIK S, FRIEDMAN L, KOLTER R. Biofilms: the matrix revisited. Trends Microbiol 2005; 13: 20-26.
4. DAVEY ME, O'TOOLE GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 2000; 64: 847-867.
5. STOODLEY P, SAUER K, DAVIES DG, COSTERTON JW. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002; 56: 187-209.
6. O'TOOLE G, KAPLAN HB, KOLTER R. Biofilm formation as microbial development. Annu Rev Microbiol 2000; 54: 49-79.
7. CUCARELLA C, SOLANO C, VALLE J, AMORENA B, LASA I, PENADES JR. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol 2001; 183: 2888-2896.
8. TOLEDO-ARANA A, VALLE J, SOLANO C, ARRIZUBIETA MJ, CUCARELLA J, LAMATA M et al. The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol 2001; 67: 4538-4545.
9. ZIEBUHR W, KRIMMER V, RACHID S, LOSSNER I, GOTZ F, HACKER J. A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Mol Microbiol 1999; 32: 345-356.
10. UBEDA C, TORMO MA, CUCARELLA C, TROTONDA P, FOSTER TJ, LASA I et al. Sip, an integrase protein with excision, circularization and integration activities, defines a new family of mobile Staphylococcus aureus pathogenicity islands. Mol Microbiol 2003; 49: 193-210.
11. KAPLAN JB, RAGUNATH C, RAMASUBBU N, FINE DH. Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase activity. J Bacteriol 2003; 185: 4693-4698.
12. KAPLAN JB, RAGUNATH C, VELLIYAGOUNDER K, FINE DH, RAMASUBBU N. Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2004; 48: 2633-2636.
13. KAPLAN JB, VELLIYAGOUNDER K, RAGUNATH C, ROHDE H, MACK D, KNOBLOCH JK et al. Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J Bacteriol 2004; 186: 8213-8220.
14. WU H, SONG Z, HENTZER M et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J Antimicrob Chemother 2004; 53: 1054-1061.
15. HUME EB, BAVEJA J, MUIR B, SCHUBERT TL, KUMAR N, KJELLEBERG S et al. The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials 2004; 25: 5023-5030.
16. GOV Y, BITLER A, DELL'ACQUA G, TORRES JV, BALABAN N. RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis. Peptides 2001; 22: 1609-1620.
17. VALLE J, TOLEDO-ARANA A, BERASAIN C, GHIGO JM, AMORENA B, PENADES B et al. SarA and not 6B is essential for biofilm development by Staphylococcus aureus. Mol Microbiol 2003; 48: 1075-1087.
18. AUSMEES N, MAYER R, WEINHOUSE H, VOLMAN G, AMIKAM D, BENZIMAN M et al. Genetic data indicate that proteins containing the GGDEF domain possess diguanylate cyclase activity. FEMS Microbiol Lett 2001; 204: 163-167.
19. GARCIA B, LATASA C, SOLANO C, PORTILLO FG, GAMAZO C, LASA I. Role of the GGDEF protein family in Salmonella cellulose biosynthesis and biofilm formation. Mol Microbiol 2004; 54: 264-277.
20. BOMCHIL N, WATNICK P, KOLTER R. Identification and characterization of a Vibrio cholerae gene, mbaA, involved in maintenance of biofilm architecture. J Bacteriol 2003; 185: 1384-1390.
21. TISCHLER AD, CAMILLI A. Cyclic diguanylate (c-di-GMP) regulates Vibrio cholerae biofilm formation. Mol Microbiol 2004; 53: 857-869.
22. KIRILLINA O, FETHERSTON JD, BOBROV AG, ABNEY J, PERRY RD. HmsP, a putative phosphodiesterase, and HmsT, a putative diguanylate cyclase, control Hms-dependent biofilm formation in Yersinia pestis. Mol Microbiol 2004; 54: 75-88.
23. TOLEDO-ARANA A, MERINO N, VERGARÁ M, DEBARBOUILLE M, PENADES JR, LASA I. Staphylococcus aureus develops an alternative ica-independent biofilm in the absence of arlRS two-component system. J Bacteriol 2005; In press.
24. COSTERTON JW, STEWART PS. Biofilms and device-related infections. En: Nataro JP, Blaser MJ, Cunningham-Rundles S, eds. Persitent Bacterial Infections. Washintong: American Society of Microbiology 2000: 423-439.
25. COSTERTON JW, STEWART PS, GREENBERG EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-1322.
26. WILSON M. Bacterial biofilms and human disease. Sci Prog 2001; 84: 235-254.
27. GRISTINA AG. Biofilms and chronic bacterial infections. Clin Microbiol Newsletter 1994; 16: 171-178.
28. MAH TF, O'TOOLE GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34-39.
29. STEWART PS, COSTERTON JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-138.
30. DONLAN RM, COSTERTON JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-193.
31. AMORENA B, GRACIA E, MONZÓN M et al. Antibiotic susceptibility of Staphylococcus aureus in biofilms developed in vitro. J Antimicrobial Chem 1999; 44: 43-55.
32. CERI H, OLSON ME, STREMICK C, READ RR, MORCK D, BURET A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-1776.
33. MESSING B. Catheter-sepsis during home parenteral nutrition: use of the antibiotic-lock technique. Nutrition 1998; 14: 466-468.
34. STECKELBERG JM, ROUSE MS, TALLAN BM, OSMON DR, HENRY NK, WILSON WR. Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis. Antimicrob Agents Chemother 1993; 37: 554-558.
35. EHRLICH GD, ZE HU F, LIN A, COSTERTON JW, POST JC. Intelligent implants to battle biofilms. ASM News 2004; 70: 127-133.